Обучается переводу с помощью примеров, переведенных людьми.
Добавлены профессиональными переводчиками и компаниями и на основе веб-страниц и открытых баз переводов.
box-calf
boxcalf
Последнее обновление: 2014-11-21
Частота использования: 4
Качество:
public statement on lactose prepared using calf rennet:
public statement on lactose prepared using calf rennet:
a concentração não reforça por si só a posição de mercado da bt industries ab, da gislaved folie ab e da elmo-calf ab.
the concentration does not by itself reinforce the market position of bt industries ab, gislaved folie ab and elmo-calf ab.
specific publicado para consulta em julho de cvmp/vich/545/00 recommendations for feline 2000 grupo de trabalho " imunologia " do cvmp número de referência linhas de orientação situação requirements for combined veterinary cvmp/iwp/52/97 aprovada em março de 2000 vaccines dna vaccines non-amplifiable in cvmp/iwp/07/98 aprovada em março de 2000 eukaryotic cells for veterinary use duration of protection achieved by emea/cvmp/682/99 aprovada em outubro de 2000 veterinary vaccines publicado para consulta em março emea/cvmp/852/99 field trials with veterinary vaccines de 2000 requirements and controls applied to bovine serum (foetal or calf) used in the publicado para consulta em outubro emea/cvmp/743/00 protection of immunological veterinary de 2000 medicinal products grupo de trabalho " farmacovigilância " do cvmp número de referência linhas de orientação situação conduct of post-marketing surveillance emea/cvmp/044/99 aprovada em abril de 2000 studies of veterinary medicinal products management of adverse event reports publicado para consulta em julho de cvmp/vich/547/00 (aers) 2000 grupo de trabalho " segurança " do cvmp número de referência linhas de orientação situação assessment of the effect of antimicrobial emea/cvmp/276/99 aprovada em março de 2000 substances on dairy starter cultures determination of withdrawal periods for emea/cvmp/473/98 aprovada em março de 2000 milk environmental impact assessment (eias) cvmp/vich/592/98 aprovada em julho de 2000 for veterinary medicinal products -phase 1 risk analysis approach for residues of publicado para consulta em maio de emea/cvmp/187/00 veterinary medicinal products in food of 2000 animal origin safety studies for veterinary drug residues publicado para consulta em julho de cvmp/vich/526/00 in human food:
cvmp immunologicals working partyreference number cvmp/iwp/52/97 cvmp/iwp/07/98 emea/cvmp/682/99 emea/cvmp/852/99 emea/cvmp/743/00cvmp pharmacovigilance reference number emea/cvmp/044/99 cvmp/vich/547/00guidelines/status requirements for combined veterinary vaccines adopted march 2000 dna vaccines non-amplifiable in eukaryotic cells for veterinary use adopted march 2000 duration of protection achieved by veterinary vaccines adopted october 2000 field trials with veterinary vaccines released for consultation march 2000 requirements and controls applied to bovine serum (foetal or calf) used in the protection of immunological veterinary medicinal products released for consultation october 2000working partyguidelines/status conduct of post-marketing surveillance studies of veterinary medicinal products adopted april 2000 management of adverse event reports (aers) released for consultation july 2000cvmp safety working partylinesstatus numberreference emea/cvmp/276/99 emea/cvmp/473/98 cvmp/vich/592/98emea/cvmp/187/00cvmp/vich/526/00 cvmp/vich/525/00guidelines/status assessment of the effect of antimicrobial substances on dairy starter cultures adopted march 2000 determination of withdrawal periods for milk adopted march 2000 environmental impact assessment (eias) for veterinary medicinal products -phase 1 adopted july 2000 risk analysis approach for residues of veterinary medicinal products in food of animal origin released for consultation may 2000 safety studies for veterinary drug residues in human food: